Data / Form D filings / Tentarix Biotherapeutics, LP
Tentarix Biotherapeutics, LP: Form D filings
Tentarix Biotherapeutics, LP, a biotechnology company in San Diego, CA, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on September 7, 2023, reports $35 million sold of a $35 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10355 Science Center Drive, Suite 120, San Diego, CA, 92121
- Phone
- (858) 587-4815
- Industry
- Biotechnology
- Entity type
- Limited Partnership
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1822549
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 7, 2023 | New notice | $34,999,997 | $34,999,997 | 5 | Aug 28, 2023 | sec.gov | |
| Sep 16, 2020 | New notice | $50,000,000 | $8,000,000 | $42,000,000 | 4 | Jul 13, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Kang | Director | |
| Allyson F. Tighe | Director | |
| Thomas F. Bumol | Director | |
| Srinivas Akkaraju | Director | |
| Paul Grayson | Executive Officer, Director | |
| Jerel Davis | Director | |
| Margaret F. Karow | Executive Officer | |
| Stephen F. Demarest | Executive Officer | |
| Donald J. Santel | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 4, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tentarix Biotherapeutics, LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.